There is no known direct interaction between nicotine and semaglutide, and no reason to think nicotine changes how the medication is absorbed or how well it works.<\/p>\n
What is worth knowing is a finding that runs the other direction. In a randomized clinical trial of once-weekly semaglutide in adults with alcohol use disorder, a subgroup who were current cigarette smokers showed greater relative reductions in cigarettes per day compared with placebo.<\/p>\n
That was a secondary observation in a small trial about alcohol, not a study of smoking cessation, and it does not make this a stop-smoking medication. It does fit a broader pattern that researchers are actively investigating: these medications appear to affect reward and craving pathways beyond food.<\/p>\n
Does mean:<\/strong> if you have found yourself smoking or vaping less since starting, that is a recognized observation rather than something you imagined.<\/p>\n Does not mean:<\/strong> semaglutide is a treatment for nicotine dependence, or that you should expect this to happen, or that it substitutes for established cessation support.<\/p>\n The evidence base here is early. Treat any reduction in cravings as a useful tailwind if it happens, not as a plan.<\/p>\n This is worth saying plainly: stopping smoking is one of the highest-value health changes available, and it does not need to wait for a convenient moment.<\/p>\n If reduced cravings on this medication have made it feel more achievable, that is a good time to act on it. Established approaches, including nicotine replacement, prescription medications, and behavioural support, are considerably more effective than willpower and can be combined.<\/p>\n Two points specific to your situation:<\/p>\n Tell your provider what you take<\/strong>, including this medication, before starting any cessation medication, so interactions can be checked properly against your full list.<\/p>\n Weight gain concerns are the usual barrier<\/strong>, and this is the unusual moment where that barrier is lower. People frequently avoid quitting because they fear gaining weight. If you are already on treatment that is managing your weight, that objection carries less force than it normally would. That is worth raising with your provider as a reason to attempt it now.<\/p>\n Consider this scenario: a patient who has wanted to quit for years, but always relapsed during the weight gain that followed, is four months into treatment and finding cigarettes less appealing. Two of the usual obstacles are weaker at the same time. That is a window worth using rather than noting.<\/p>\n Some practical overlaps worth knowing.<\/p>\n Nicotine affects the digestive system<\/strong>, and it can contribute to reflux by relaxing the valve at the top of the stomach. Combined with slowed gastric emptying on this medication, that makes reflux more likely.<\/p>\n Smoking on an empty stomach<\/strong> is more likely to cause nausea, and empty stomachs are common on this medication.<\/p>\n Nicotine is an appetite suppressant<\/strong> in its own right. If you are already eating very little, that combination is worth watching. Adequate protein and fluid matter throughout treatment, and under-eating produces fatigue, feeling cold, and hair shedding rather than better results.<\/p>\n The same points apply. No known interaction with semaglutide, and the same reflux and appetite considerations.<\/p>\n Nicotine pouches and gum can also cause nausea and hiccups on an empty stomach, which is worth knowing since both are already common on this medication and it is easy to attribute them to the wrong cause.<\/p>\n Mention nicotine use as a matter of course. It gets left off medical histories routinely and it is relevant to more than people assume:<\/p>\n If you use it, say so plainly rather than approximately. Nobody is going to lecture you, and understated answers produce worse care.<\/p>\n Worth flagging because it connects. A modest increase in resting heart rate is a recognized effect of this medication class, and nicotine also raises heart rate and blood pressure.<\/p>\n That combination is not a reason for alarm, and it is a reason to mention both when your cardiovascular picture is being assessed. Our guides on Ozempic and heart health<\/a> and how GLP-1 medications affect blood pressure over time<\/a> cover what to expect.<\/p>\n Contact your provider if:<\/p>\n That fourth point deserves attention. Using nicotine deliberately to reduce appetite on top of a medication that already does so is worth discussing openly rather than managing privately.<\/p>\n No known interaction. There is an early, secondary finding that semaglutide reduced cigarettes per day in a small subgroup, which is interesting rather than actionable on its own. If cravings have dropped and you want to quit, this is an unusually good moment, because the weight gain concern that usually derails attempts is already being handled. Tell your provider you use nicotine, and ask for proper cessation support rather than relying on a side effect.<\/p>\nIf you want to stop smoking<\/h2>\n
Nicotine and the digestive side<\/h2>\n
Vaping and nicotine pouches<\/h2>\n
What to tell your provider<\/h2>\n
\n
The cardiovascular angle<\/h2>\n
When to call your provider<\/h2>\n
\n
The short version<\/h2>\n